A suspension of Dox-np (10 mg/mL) in distilled water was vortexed for 30 seconds to break up nanoparticle aggregates, followed by sonication on ice for 1 minute. The nanoparticle size distribution profile was assessed using DynaPro NanoStar (Wyatt Technology, Santa Barbara, CA). All readings were executed in triplicate and compiled with an acquisition length of 5 seconds and a total of 40 acquisition attempts. Average particle hydrodynamic diameter was calculated from the results.
Supporting Information Dynamic Light Scattering (DLS)
A suspension of Dox-np (10 mg/mL) in distilled water was vortexed for 30 seconds to break up nanoparticle aggregates, followed by sonication on ice for 1 minute. The nanoparticle size distribution profile was assessed using DynaPro NanoStar (Wyatt Technology, Santa Barbara, CA). All readings were executed in triplicate and compiled with an acquisition length of 5 seconds and a total of 40 acquisition attempts. Average particle hydrodynamic diameter was calculated from the results.
Scanning Electron Microscopy (SEM)
Nanoparticles were plated on poly-L-lysine-coated coverslips, critical point dried using liquid CO2 in a Samdri-795 Critical Point Dryer (Tousimis, Rockville, MD), and sputter coated with chromium in a Q150T ES Sputter Coater (Quorum Technologies Ltd, East Sussex, UK). Samples were examined under a Supra Field Emission Scanning Electron Microscope (Carl Zeiss Microscopy, Peabody, MA) with accelerating voltage of 3 kV.
Maximum Encapsulation of Dox
The theoretical maximum of Dox encapsulated within Dox-np was calculated using the weight of doxorubicin used in synthesis and the total weight of the synthesized nanoparticles, such that: Theoretical maximum = (Total doxorubicin used in synthesis / Total weight of synthesized np)/(weight of np used in release experiment/ volume of solvent used in experiment). Dox-np variants were suspended in dimethyl sulfoxide (DMSO) at concentrations with maximum theoretical yields of either 0.32 mM or 0.08 mM (12 mg nanoparticle/mL = 0.32 mM maximum theoretical yield). The samples were agitated at 37°C for 24 hours and then pelleted at 13.2k rpm for 5 minutes. In order to quantify the concentration of nano-encapsulated Dox in Dox-np, a reference sample of 2 mg/ml of Dox was obtained and diluted to 0.08 mM in DMSO. Spectrophotometric analysis of the standard showed an absorption peak at 481 nm. The absorption value at this wavelength was used to calculate an absorption coefficient for Dox in DMSO. The supernatant from each Dox-np sample was measured and the concentration of Dox then calculated.
In Vitro Release kinetics
The intrinsic fluorescence of Dox was utilized to analyze the release characteristics of the Dox-np variants via spectrophotometry (Thermo Scientific, Waltham, MA). Individual aliquots of 10 mg/ml Dox-np dispersed in phosphate buffered saline (PBS, pH=7.4) were incubated on a rotator at 4 °C or 37
°C for a total of 48 h. At various time points, aliquots were pelleted for 5 minutes at 13.2k rpm and the supernatant analyzed using UV-Vis Spectrophotometer. Spectrophotometer settings utilized for Dox were as follows: wavelength = 488 nm, extinction coefficient = 11500 1/(M-cm), atomic mass = 543.52.
Cell Culture
The cancer cell lines A549 (human lung adenocarcinoma), HEY (human ovarian adenocarcinoma), MD-MB-157, Hs578T and MDA-MB-468 (all human TNBC) were purchased from American Type Culture Collection (ATCC; Manassas, VA) and cultured according to ATCC instructions. BRCA mutant SUM149PT cells were obtained from Steve Ethier, University of Michigan. Only early passage cells (5-15) were used in experiments. Cells were authenticated by short tandem repeat profiling before use.
Cell Proliferation Assays
A sulforhodamine B (SRB) colorimetric assay was used to screen for anti-tumor efficacy of Dox compared to Dox-np (S1). Briefly, cells were seeded into 96-well plates at densities ranging from 900-1500 cells per well, and allowed to attach for 24 hours. Six replicate wells were incubated with 800 nM of Dox-np variants, clinical grade Dox and control-np, and 2-fold serial dilutions were made for a total of 9 evaluable doses per treatment. Cells were incubated for 3 cell doublings (3-5 days), after which, adherent cells were fixed with 10% trichloroacetic acid (TCA), washed 5 times with distilled water and stained with 0.4% SRB in 1% acetic acid for 10 minutes. Plates were washed 3 times with 0.1% acetic acid, air-dried, photographed and solubilized in 100 µl unbuffered 10 mM Tris solution (pH 10). Optical densities at 564 nm (OD564) were obtained and drug effect across multiple doses was calculated as % of vehicle-only control. Experiments were repeated a minimum of 3 times.
Multiparameter Dose-Response Modeling
Dose-response curves for clinical grade Dox and Dox-np were generated by fitting values to a logistical sigmoidal model using nonlinear least-squares regression in the R statistical software suite (http://www.R-project.org/)(S2). Dose-response components, namely EMax, AUC and EC50, were computed and used to describe features of dose-response relationships and to provide a robust comparison of profiles of Dox-np versus Dox. Data were presented as box -whisker plots showing median (horizontal line) and interquartile range (boxes). The advantage of the multiparameter method is to circumvent over-reliance on EC50, otherwise known as potency, which typically describes a concentration corresponding to the half-maximal effect associated with proliferative arrest. Overreliance on potency fails to account for more clinically relevant features of the dose-response relationship, such as EMax, a measure of efficacy that correlates well with concentrations that cause tumor cell death, and AUC, a metric that combines potency and efficacy into one. Assays were done over 3 cell doublings to minimize concerns that efficacy would be skewed by the rate of cell division (S3).
Fluorescent Bead Uptake
Log-phase growth cancer cells seeded in glass-bottomed plates were incubated in serum-free Dulbecco's modified Eagle's medium supplemented with L-glutamine containing red fluorescent latex beads (0.5 μm mean particle size -L3020, Sigma-Aldrich, St. Louis, Missouri, United States) for 1 hour. Cells were washed 4× in warm PBS containing 0.4% trypan blue to quench extracellular fluorescence, and then fixed in 4% paraformaldehyde in PBS for 20 minutes at room temperature. Cells were washed a further 2× in cold PBS before imaging fluorescent bead uptake. Six fields were imaged at 40× magnification corresponding to 190-550 cells, depending on the cell line. Bead uptake was calculated as the number of cells containing fluorescent beads as a percentage of the total number of cells imaged (by phase contrast). The range in bead uptake per cell line was also determined.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism software (GraphPad Software, Inc., La Jolla, CA), unless otherwise stated. Differences in a given dose-response parameter between Dox-np versus Dox were analyzed using a nonparametric Wilcoxon signed rank test. A P-value <0.05 was considered statistically significant in all cases. Data presented reflect a composite analysis of at least 3 independent experiments. 
